PATENT CLAIM ANALYSIS

Application Number: 16111500
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2019-02
Patent Classification: ["514", "005900"]

Abstract:
The present system is directed in several embodiments to a method of administration of a therapeutic composition for treatment of seizures resulting from epilepsy and other seizure disorders. The method includes administering one or more therapeutic compositions comprising an effective amount of insulin directly to the subject patient's CNS, with no to minimal systemic exposure. Preferably, this method comprises administration of an effective amount of insulin to the upper third of a patient's nasal cavity, thereby bypassing the patient's blood-brain barrier and delivering the therapeutic composition directly to the patient's central nervous system.

Claim (Index 14):
The method of  claim 9 , wherein the concentration of insulin in the brain of the patient after a single dose in in the range of 1\u00d710 \u221213  to 1\u00d710 \u22128  molar.

Metadata:
- Claim Count in Document: 89.0
- Percentile: 96.0
- Lexical Diversity: 1.63492
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14202932', '14679667', '15340160', '14040915', '13650344']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.794578235256136
- 35 USC 102 Novelty (BERT): 0.5091601777146542
- Combined Prediction Score: 0.7660364295019878
- Mean Citation Score: 297.697668
- Max Citation Score: 311.47104
- Similarity Product: 291.06552175804137

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test